A patient-facing record of the most common mental health condition in the United States — what the diagnosis means, how the medications work, week by week what to expect, and what to do when the ordinary course does not go the ordinary way.
Depression is not a failure of will. It is a medical condition with measurable biology, evidence-based treatments, and a clear — if unhurried — timeline for recovery. This ledger is a plain record of how the diagnosis is made, which medications help, how long each stage takes, and where to find help when the usual path does not fit.
Sadness is a normal, useful emotion. It comes in response to events, it has a beginning and an end, and it usually responds to time, comfort, or a change in circumstances. Depression is something else. It is a clinical syndrome defined by a set of symptoms that persist for at least two weeks, cause real impairment in work, relationships, or self-care, and cannot be dismissed by willpower or a good weekend.
The two core features are persistent low mood and loss of interest or pleasure in activities that used to matter. Around these, a diagnosis of major depressive disorder typically requires several additional symptoms: changes in sleep (too much or too little), changes in appetite or weight, fatigue, difficulty concentrating or making decisions, psychomotor slowing or agitation, feelings of worthlessness or guilt, and recurrent thoughts of death or self-harm.
What depression is not: laziness, weakness, or a failure to try hard enough. The biology involves changes in the brain's monoamine systems — serotonin, norepinephrine, and dopamine — along with structural and functional changes in regions that govern mood, motivation, and reward. There are also strong contributions from genetics, chronic stress, inflammation, thyroid function, and sleep. This is why the diagnosis is made by a clinician using defined criteria, not by a self-assessment.
Depression also comes in different shapes. Major depressive disorder involves discrete episodes. Persistent depressive disorder (dysthymia) is a lower-grade but more chronic pattern lasting two years or more. Bipolar depression — depression occurring as one phase of bipolar disorder — is treated very differently, which is why every patient should be screened for a history of manic or hypomanic episodes before an antidepressant is prescribed.
The Patient Health Questionnaire-9 is the most widely used screening and severity tool in U.S. primary care and psychiatry. It asks nine questions about symptoms over the past two weeks, each scored 0 (not at all) to 3 (nearly every day). The total score (0–27) maps to a standard severity range and is used to track change over time.
The instrument is not a diagnosis. A high score does not mean a person has depression, and a low score does not mean they do not. What the PHQ-9 does well is track severity across visits, making it useful for measuring whether a treatment is working. The ninth question — about thoughts of self-harm — is the one that requires immediate attention if answered positively.
Antidepressants do not work like painkillers. They do not lift a low mood the way a headache remedy dulls a headache. What they do is gradually shift the underlying neurochemistry so that mood, sleep, appetite, and motivation have room to recover — a process that takes weeks, not hours. The choice between classes is rarely arbitrary; it depends on the specific symptom profile, side-effect tolerance, and the presence of other conditions.
| Class | Common examples | Notes & typical use |
|---|---|---|
| SSRIs | sertraline fluoxetine escitalopram citalopram paroxetine |
First-line for most patients. Well tolerated, wide therapeutic window, extensive generic availability. First-line |
| SNRIs | venlafaxine duloxetine desvenlafaxine |
Act on serotonin and norepinephrine. Often used when SSRIs are insufficient or when chronic pain is a factor. Alternative |
| Bupropion | bupropion SR / XL | Dopamine and norepinephrine activity. No sexual side effects, may help with smoking cessation. Not used in patients with seizure history or eating disorders. Alternative |
| Mirtazapine | mirtazapine | Often chosen when insomnia and low appetite dominate. Sedating at lower doses, and frequently used as an adjunct. Specific use |
| Tricyclics | amitriptyline nortriptyline imipramine |
Effective but more side effects. Now often used at low doses for nerve pain, migraine prophylaxis, or insomnia rather than as a primary antidepressant. Reserved |
| MAOIs | phenelzine tranylcypromine |
Reserved for depression that has not responded to other classes. Require dietary restrictions and have significant drug interactions. Reserved |
Two other options matter for patients whose depression has not responded to standard trials. Esketamine (a nasal spray derived from ketamine) is approved for treatment-resistant depression and must be administered under medical supervision. Transcranial magnetic stimulation (TMS) is a non-invasive option for patients who have not responded to two or more antidepressants. Both are considerably more expensive than generic oral antidepressants and are typically pursued when the standard sequence has failed.
The popular idea that depression is simply "a chemical imbalance" is an oversimplification. Recent reviews have questioned how directly serotonin levels explain depression — but this does not mean antidepressants do not work. The evidence that they help in moderate to severe depression is strong. The mechanism is more complex than a single neurotransmitter, and the biology of depression involves much more than any one chemical.
The most common reason a patient stops an antidepressant too early is that the medication "is not working" in the first week or two. The reality is that most antidepressants take two to four weeks to show benefit and up to six to eight weeks for full effect — and some symptoms improve before others. Understanding the schedule in advance is what prevents an early abandonment.
Blood levels are still rising. What the patient may notice in the first week are side effects rather than benefits — mild nausea, sleep changes, jitteriness, or appetite shifts. These usually settle within two to three weeks. The medication should not be judged yet.
Sleep and appetite typically respond before mood. A patient may start sleeping better or eating normally before they feel emotionally better — which can be confusing. Some early improvement in these domains is a good prognostic sign.
This is the phase where most patients feel the change. Interest in activities returns slowly. Concentration improves. Self-critical thoughts soften. If by six weeks there is no meaningful change, the dose is usually reassessed.
Adequate trial means the full therapeutic dose for at least 6–8 weeks. If partial improvement: increase dose. If none: switch medication. About 1 in 3 patients does not respond to the first medication tried. This is expected, not a personal failure.
Once a patient feels well, the medication is usually continued for 6 to 12 months to consolidate the response. Stopping as soon as one feels better substantially increases the risk of relapse — and the second episode is often harder to treat than the first.
For patients with a first episode, a gradual taper under medical supervision is often reasonable after a year of stability. For patients with recurrent episodes, longer-term maintenance may be recommended. Stopping should always be tapered — never abrupt.
Every antidepressant has side effects. Most are manageable, many fade, and a few require a change in medication. What matters is knowing which category you are dealing with — and telling the prescriber instead of quietly stopping.
Most common in the first one to two weeks, particularly with SSRIs and SNRIs. Taking the medication with food often helps. These effects usually resolve on their own and are not a reason to stop the medication without consulting the prescriber.
Reduced libido, delayed orgasm, or difficulty with arousal affect a substantial minority of patients on SSRIs and SNRIs. These do not usually resolve on their own. Because they are among the most common reasons patients stop medication, they are worth raising early. Bupropion is a common switch when this is the primary issue.
Some antidepressants are activating (fluoxetine, bupropion) and can cause insomnia if taken late. Others are sedating (mirtazapine, paroxetine) and can cause daytime grogginess. Timing changes often fix this — activating drugs in the morning, sedating drugs at night.
Some patients gain weight on long-term SSRI therapy; others lose it, especially early on. Mirtazapine is well known for appetite stimulation and weight gain. If weight change is a concern, discuss it early — later in treatment, alternatives are more difficult to change to.
A rare but potentially serious reaction when serotonergic drugs are combined — including MAOIs, triptans, tramadol, and some supplements. Signs include agitation, confusion, fever, muscle rigidity, and rapid heart rate. This is a medical emergency requiring immediate care.
Most common in older adults on SSRIs or SNRIs. Symptoms include confusion, headache, weakness, and unsteadiness. Blood sodium should be monitored in at-risk patients. If symptoms appear, contact a clinician promptly.
In some patients, especially those under 25, antidepressants can be associated with increased suicidal thinking during the first few weeks. This is not a reason to avoid treatment — it is a reason to be closely monitored during the initiation phase. Any new self-harm thought should be reported immediately.
Stopping an antidepressant suddenly can cause dizziness, nausea, flu-like symptoms, "brain zaps," and severe mood swings. Paroxetine and venlafaxine are the worst offenders. Tapering should always be done gradually and with a prescriber's guidance.
Thoughts of suicide are a symptom of depression — not a personal failing, and not a permanent state. They can be treated, and they frequently pass once the crisis is over. What they require is immediate support.
In the United States, the 988 Suicide & Crisis Lifeline is available 24 hours a day by calling or texting 988. You can also go to the nearest emergency department or call 911. If you are helping someone else, stay with them and help them contact a crisis line or emergency services.
Call or text 988 · National Suicide & Crisis LifelineAlmost every commonly prescribed antidepressant is available as a low-cost generic in the United States. Sertraline, fluoxetine, escitalopram, citalopram, bupropion, venlafaxine, duloxetine, and mirtazapine are all produced by multiple manufacturers and priced well below their original brand versions. For most patients, the medication itself is one of the least expensive items in their pharmacy bag.
What varies — and varies by more than five-fold between licensed sellers — is the price the pharmacy charges for the same tablet on the same day. A live prescription price comparison shows the current range in about two minutes, and the same logic applies to every generic on the psychiatric list. If you have not checked prices since starting a long-term antidepressant, it is worth the check — the savings carry forward every month.
If you are filling an online refill for the first time, the process is documented step by step in this how to order prescriptions online guide — prescription first, licensed seller second, small first order third. And for a plain-language reference on how generics differ from brand-name drugs, this generic drug guide covers the FDA standard that makes the price difference rational rather than suspicious.
Before you sign for a seller, verify them. A working VIPPS seal that resolves to a live NABP record, a real U.S. street address, and a prescription requirement that cannot be waived. A transparency page like this one about Metformin4You is a reasonable example of the standard to expect.
One note specific to antidepressants: do not skip doses, stretch prescriptions, or switch to a lower dose on your own to save money. These responses to cost pressure are common, and they undermine the treatment more than any missed refill would. If the medication is unaffordable, tell the prescriber — there is almost always a cheaper generic in the same class or an assistance program that fits the budget.
Medication is one lever. Psychotherapy is another — and for mild to moderate depression, the evidence for structured therapy (CBT, behavioral activation, interpersonal therapy) is on par with medication. Alongside these, six daily habits reliably improve outcomes in clinical studies, not as substitutes for treatment but as what makes treatment work better.
150 minutes per week of moderate activity has an effect size comparable to medication in mild to moderate depression. It also reduces relapse risk.
Consistent wake times — more than total hours — improve mood regulation. Sleep disruption is both a symptom and a driver of depression.
Isolation is both a symptom and an accelerant. Even short, low-effort contact — a message, a walk with one person — measurably improves outcomes.
Depression erodes routine. Behavioral activation — doing things before feeling motivated — is a core evidence-based approach. Action precedes motivation, not the other way around.
Alcohol is a depressant, disrupts sleep architecture, and interacts with many antidepressants. Reducing intake often produces visible mood improvement within weeks.
Morning light exposure helps regulate the circadian system. For seasonal depression, light therapy is a first-line treatment. For year-round depression, it is a useful complement.
Most antidepressants are available as low-cost generics, and the same tablet can cost five to ten times more at one licensed pharmacy than another. A two-minute comparison across licensed U.S. sellers is the highest-yield habit you can add to a treatment plan — no prescription change required. Begin with the current Metformin price comparison as a live demonstration of how wide the spread runs.
Open the price comparison